Multicentre experience with two frozen elephant trunk prostheses in the treatment of acute aortic dissection†.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
01 Sep 2019
Historique:
received: 16 10 2018
revised: 23 01 2019
accepted: 24 01 2019
pubmed: 8 3 2019
medline: 7 10 2020
entrez: 8 3 2019
Statut: ppublish

Résumé

The aim of this study was to evaluate early- and mid-term outcome and aortic remodelling in patients undergoing implantation of 2 different frozen elephant trunk prostheses, either the Thoraflex™ hybrid (Vascutek, Inchinnan, UK) and the E-vita Open (Jotec Inc., Hechingen, Germany) for acute aortic dissection. All consecutive patients [n = 88; median age 59 (49-67) years; 69% male] undergoing surgery with a frozen elephant trunk prosthesis for acute aortic dissection from August 2005 until March 2018 were included in this study. The Thoraflex™ device was implanted in 55 patients and the E-vita Open graft in 33 patients. Preoperative characteristics did not differ significantly between groups. There was also no statistically significant difference in postoperative outcome: in-hospital mortality (11% vs 12%; P > 0.99), stroke (18% vs 6%; P = 0.12) and spinal cord injury (6% vs 6%; P > 0.99). While there was no statistically significant difference in the occurrence of distal stent graft-induced new entries (16% vs 18%; P = 0.77), there was a significantly higher rate of secondary endovascular aortic interventions in the Thoraflex™ hybrid group (22% vs 0%; P = 0.003). There was a trend towards a higher rate of false lumen thrombosis at the level of the stent graft (74% vs 95%; P = 0.085) and was comparable at the thoraco-abdominal transition (53% vs 80%; P = 0.36) 1 year after implantation of the prostheses. In this comparison of 2 frozen elephant trunk prostheses, there is no evidence that different surgical techniques influence in-hospital outcome. At 1-year follow-up, patients who underwent implantation of the E-vita Open prosthesis showed a significantly reduced rate of secondary aortic interventions and a trend towards a higher rate of false lumen thrombosis which might be attributed to a longer coverage of the descending aorta due to a longer stent graft design and significantly more frequent implantation in zone 3.

Identifiants

pubmed: 30844055
pii: 5371195
doi: 10.1093/ejcts/ezz037
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

572-578

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Tim Berger (T)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, University Freiburg, Freiburg, Germany.
Medical Faculty, Albert Ludwigs-University Freiburg, Freiburg, Germany.

Gabriel Weiss (G)

Department of Cardiovascular Surgery, Hospital Hietzing, Vienna, Austria.

Andreas Voetsch (A)

Department of Cardiovascular Surgery, Landeskrankenhaus Salzburg, Paracelsus Medical University, Salzburg, Austria.

Zsuzsanna Arnold (Z)

Department of Cardiovascular Surgery, Hospital Hietzing, Vienna, Austria.

Maximilian Kreibich (M)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, University Freiburg, Freiburg, Germany.
Medical Faculty, Albert Ludwigs-University Freiburg, Freiburg, Germany.

Bartosz Rylski (B)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, University Freiburg, Freiburg, Germany.
Medical Faculty, Albert Ludwigs-University Freiburg, Freiburg, Germany.

Philipp Krombholz-Reindl (P)

Department of Cardiovascular Surgery, Landeskrankenhaus Salzburg, Paracelsus Medical University, Salzburg, Austria.

Andreas Winkler (A)

Department of Cardiovascular Surgery, Landeskrankenhaus Salzburg, Paracelsus Medical University, Salzburg, Austria.

Markus Mach (M)

Department of Cardiovascular Surgery, Hospital Hietzing, Vienna, Austria.

Daniela Geisler (D)

Department of Cardiovascular Surgery, Hospital Hietzing, Vienna, Austria.

Rainald Seitelberger (R)

Department of Cardiovascular Surgery, Landeskrankenhaus Salzburg, Paracelsus Medical University, Salzburg, Austria.

Mathias Siepe (M)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, University Freiburg, Freiburg, Germany.
Medical Faculty, Albert Ludwigs-University Freiburg, Freiburg, Germany.

Friedhelm Beyersdorf (F)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, University Freiburg, Freiburg, Germany.
Medical Faculty, Albert Ludwigs-University Freiburg, Freiburg, Germany.

Martin Grabenwoeger (M)

Department of Cardiovascular Surgery, Hospital Hietzing, Vienna, Austria.

Martin Czerny (M)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, University Freiburg, Freiburg, Germany.
Medical Faculty, Albert Ludwigs-University Freiburg, Freiburg, Germany.

Roman Gottardi (R)

Department of Cardiovascular Surgery, Landeskrankenhaus Salzburg, Paracelsus Medical University, Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH